{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:45:01Z","timestamp":1770295501525,"version":"3.49.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003477","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T12:10:15Z","timestamp":1461240615000},"page":"e3477","source":"Crossref","is-referenced-by-count":15,"title":["Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease"],"prefix":"10.1097","volume":"95","author":[{"given":"Annika","family":"Gauss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Geiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Schaefert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Zwickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zawierucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Klute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-44-20210226","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MIB.0000000000000272","article-title":"Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis","volume":"21","author":"Huppertz-Hauss","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R2-44-20210226","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.crohns.2011.10.001","article-title":"Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study","volume":"6","author":"H\u00f8ivik","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R3-44-20210226","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.MIB.0000218762.61217.4a","article-title":"Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease","volume":"12","author":"Bernklev","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R4-44-20210226","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ibd.21863","article-title":"Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study","volume":"18","author":"H\u00f8ivik","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R5-44-20210226","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut"},{"key":"R6-44-20210226","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ibd.20301","article-title":"Quality of life of patients with ulcerative colitis: past, present, and future","volume":"14","author":"Irvine","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R7-44-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.crohns.2013.04.007","article-title":"Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis","volume":"8","author":"van der Have","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R8-44-20210226","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/01.mib.0000234134.35713.d2","article-title":"Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis","volume":"12","author":"Zahn","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R9-44-20210226","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ecco-jcc\/jjv081","article-title":"The impact of endoscopic inflammation and mucosal healing on health related quality of life in ulcerative colitis patients","volume":"9","author":"Theede","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R10-44-20210226","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MEG.0b013e32835414b2","article-title":"Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease","volume":"24","author":"Casellas","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R11-44-20210226","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.giec.2014.03.005","article-title":"Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity","volume":"24","author":"Walsh","year":"2014","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R12-44-20210226","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MOG.0b013e3283455c8f","article-title":"Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?","volume":"27","author":"Flynn","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"R13-44-20210226","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","article-title":"Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalization over 6 years of follow-up","volume":"65","author":"Bryant","year":"2016","journal-title":"Gut"},{"key":"R14-44-20210226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.22977","article-title":"Mucosal healing in Crohn's disease: a systematic review","volume":"19","author":"De Cruz","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R15-44-20210226","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"R16-44-20210226","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.cgh.2015.05.038","article-title":"Level of fecal calprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing of ulcerative colitis","volume":"13","author":"Theede","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-44-20210226","first-page":"w13557","article-title":"Faecal calprotectin\u2014a useful tool in the management of inflammatory bowel disease","volume":"142","author":"Burri","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"R18-44-20210226","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R19-44-20210226","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/00365521.2011.584897","article-title":"Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers","volume":"46","author":"Ricanek","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"R20-44-20210226","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R21-44-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15403\/jgld.2014.1121.233.thv","article-title":"Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study","volume":"23","author":"Voiosu","year":"2014","journal-title":"J Gastrointestin Liv Dis"},{"key":"R22-44-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R23-44-20210226","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis PART 1: Definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R24-44-20210226","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","article-title":"Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings","volume":"14","author":"Sipponen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R25-44-20210226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R26-44-20210226","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R27-44-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2010.01.001","article-title":"Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity","volume":"8","author":"Vermeire","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-44-20210226","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"R29-44-20210226","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/gut.2004.056358","article-title":"Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis","volume":"54","author":"Higgins","year":"2005","journal-title":"Gut"},{"key":"R30-44-20210226","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R31-44-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2000-14868","article-title":"Validation of the new German translation version of the \u201cShort Inflammatory Bowel Disease Questionnaire\u201d (SIBDQ)","volume":"38","author":"Rose","year":"2000","journal-title":"Z Gastroenterol"},{"key":"R32-44-20210226","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R34-44-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"R35-44-20210226","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u2019Haens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R36-44-20210226","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/00365520410007971","article-title":"Normalization of fecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease","volume":"39","author":"Roseth","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"R37-44-20210226","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/MIB.0b013e3182807577","article-title":"Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases","volume":"19","author":"Nancey","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R38-44-20210226","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","article-title":"Clinical utility of faecal biomarkers for the diagnosis and management of inflammatory bowel disease","volume":"20","author":"Kopylov","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R39-44-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/clnu.2001.0503","article-title":"Crohn's disease clinical disease course and severity in obese patients","volume":"21","author":"Blain","year":"2002","journal-title":"Clin Nutr"},{"key":"R40-44-20210226","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000262276","article-title":"A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland","volume":"2","author":"Steed","year":"2009","journal-title":"Obes Facts"},{"key":"R41-44-20210226","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ibd.21585","article-title":"Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease","volume":"17","author":"Long","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R42-44-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MIB.0000000000000283","article-title":"Measures of obesity and risk of Crohn's disease and ulcerative colitis","volume":"21","author":"Khalili","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R43-44-20210226","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","article-title":"The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R44-44-20210226","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ajg.2012.453","article-title":"Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study)","volume":"108","author":"Chan","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R45-44-20210226","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","article-title":"Obesity in inflammatory bowel disease: a marker of less severe disease","volume":"60","author":"Flores","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R46-44-20210226","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","article-title":"High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors","volume":"7","author":"Nic Suibhne","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R47-44-20210226","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/pubmed\/fdi025","article-title":"The impact of obesity on health-related quality-of-life in the general adult US population","volume":"27","author":"Jia","year":"2005","journal-title":"J Public Health (Oxf"},{"key":"R48-44-20210226","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s11136-009-9541-8","article-title":"The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England","volume":"18","author":"Soltoft","year":"2009","journal-title":"Qual Life Res"},{"key":"R49-44-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11136-008-9427-1","article-title":"Obesity and health related quality of life in the general adult population of the Canary Islands","volume":"18","author":"Serrano-Aguilar","year":"2009","journal-title":"Qual Life Res"},{"key":"R50-44-20210226","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/oby.2009.27","article-title":"Overweight, medical comorbidity and health-related quality of life in a community sample of women and men","volume":"17","author":"Mond","year":"2009","journal-title":"Obesity (Silver Spring"},{"key":"R51-44-20210226","first-page":"173","article-title":"Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life","volume":"8","author":"Faust","year":"2012","journal-title":"Gastroenterol Hepatol (NY"},{"key":"R52-44-20210226","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.MIB.0000215091.77492.2a","article-title":"Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index","volume":"12","author":"Best","year":"2006","journal-title":"Inflamm Bowel Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:23:05Z","timestamp":1620958985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604190-00044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":51,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003477","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}